Literature DB >> 18470455

18F-PET-CT in extracranial paediatric oncology: when and for whom is it useful?

Sue C Kaste1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18470455     DOI： 10.1007/s00247-008-0839-4

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN： 0301-0449


× No keyword cloud information.
  42 in total

1.  PET-CT in pediatric Langerhans cell histiocytosis.

Authors:  Sue C Kaste; Carlos Rodriguez-Galindo; Mary E McCarville; Barry L Shulkin
Journal:  Pediatr Radiol       Date:  2007-05-22

Review 2.  PET/CT in the evaluation of childhood sarcomas.

Authors:  M Beth McCarville; Ryan Christie; Najat C Daw; Sheri L Spunt; Sue C Kaste
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

Review 3.  Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions.

Authors:  L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

4.  Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.

Authors:  Y Sugawara; S J Fisher; K R Zasadny; P V Kison; L H Baker; R L Wahl
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

5.  18F-FDG PET in children with lymphomas.

Authors:  Gisele Depas; Caroline De Barsy; Guy Jerusalem; Claire Hoyoux; Marie-Françoise Dresse; Marie-France Fassotte; Nancy Paquet; Jacqueline Foidart; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-24       Impact factor: 9.236

6.  Varying degrees of FDG uptake in multiple benign neurofibromas on PET/CT.

Authors:  J M Son; M I Ahn; K D Cho; J Yoo; Y H Park
Journal:  Br J Radiol       Date:  2007-09       Impact factor: 3.039

7.  Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.

Authors:  J D Lucas; M J O'Doherty; J C Wong; J B Bingham; P H McKee; C D Fletcher; M A Smith
Journal:  J Bone Joint Surg Br       Date:  1998-05

8.  Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography.

Authors:  Douglas S Hawkins; Joseph G Rajendran; Ernest U Conrad; James D Bruckner; Janet F Eary
Journal:  Cancer       Date:  2002-06-15       Impact factor: 6.860

9.  Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.

Authors:  B L Shulkin; R J Hutchinson; V P Castle; G A Yanik; B Shapiro; J C Sisson
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

10.  Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison.

Authors:  Harry Agress; Benjamin Z Cooper
Journal:  Radiology       Date:  2003-12-29       Impact factor: 11.105
View more
  4 in total

Review 1.  PET/CT in paediatric oncology: indications and pitfalls.

Authors:  Christiane Franzius; Kai Uwe Juergens
Journal:  Pediatr Radiol       Date:  2009-06

Review 2.  PET-CT in children: where is it appropriate?

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2011-08-17

Review 3.  Malignant tumours of the kidney: imaging strategy.

Authors:  Anne M Smets; Jan de Kraker
Journal:  Pediatr Radiol       Date:  2010-04-30

Review 4.  123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Authors:  Gitta Bleeker; Godelieve A M Tytgat; Judit A Adam; Huib N Caron; Leontien C M Kremer; Lotty Hooft; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.